The national congress of the European Society for Medical Oncology represents one of the most important annual events for European oncology. During the congress, significant new developments are presented, with potential impact on clinical practice.
AIOM – Italian Association of Medical Oncology has decided to dedicate a special edition of its Oncology Wednesdays to this important event on November 25th, during which the main new findings from the Congress have been highlighted, with a particular focus on Italian research selected for oral presentations.
Among them Dr. Cavalieri from INT presented “Primary endpoint analysis of the BD4QoL study, a multicenter randomized trial for monitoring quality of life by intelligent tools in head and neck cancer survivors after curative treatment”
